
BTMD · NASDAQ
biote Corp.
$1.24 +0.11 (+9.73%)
Company overview
Biote Corp. operates in the medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patients' hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irving, Texas.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Exchange
- NASDAQ
- Market cap
- $54.7M
- Employees
- 217
- Headquarters
- Irving, TX
- Website
- biote.com
- CEO
- Bret Christensen
- Listed
- April 28, 2021
- P/E
- 2.49
- Dividend yield
- 0.00%
Company financials
- Revenue
- $188M
- Gross profit
- $129M
- Operating income
- $32M
- EBITDA
- $35.8M
- Net income
- $15.6M
- EPS
- $0.50
- Total assets
- $89M
- Total debt
- $108M
- Gross margin
- 68.45%
- Net margin
- 8.29%
- Earnings yield
- 40.15%
Showing FY 2025
News